Skip to main content

Complete Genomics, Inc. (NASDAQ:GNOM) Investor Investigation Over Potential Breaches Of Fiduciary Duties In Connection With The Proposed Takeover By BGI-Shenzhen

  • If you purchased shares of the Complete Genomics, Inc. (NASDAQ:GNOM) prior to September 17, 2012, and currently hold any of those NASDAQ:GNOM shares, you have certain options and you should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please use this form. You may also send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Investigation Overview

Sept. 18, 2012 (Shareholders Foundation) -- An investigation on behalf of investors in Complete Genomics, Inc. (NASDAQ:GNOM) shares was announced concerning whether the offer by BGI-Shenzhen to acquire Complete Genomics, Inc. for $3.15 per NASDAQ:GNOM share and the takeover process are unfair to investors in Complete Genomics shares. The investigation by a law firm concerns whether ce...



You must register (for free) or login to view the entire investigation.